Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laura Wood

Showing results (21-30 of 74) with videos related to

Pageof 8
Sort By:
Clinical Genitourinary Cancer|July 25, 2006
Adjuvant subcutaneous interleukin-2 in patients with resected renal cell carcinoma: a pilot studyNavneet S Majhail, Laura Wood, Paul Elson, et al.
Investigational New Drugs|November 6, 2004
Phase II study of oral bis (aceto) ammine dichloro (cyclohexamine) platinum (IV) (JM-216, BMS-182751) given daily x 5 in hormone refractory prostate cancer (HRPC)Tahir Latif, Laura Wood, Cindy Connell, et al.
Investigational New Drugs|May 10, 2006
Phase I trial of thalidomide and interleukin-2 in patients with metastatic renal cell carcinomaThomas Olencki, Sareena Malhi, Tarek Mekhail, et al.
Nursing Outlook|September 28, 2014
Role of the registered nurse in primary health care: meeting health care needs in the 21st centuryJanice Smolowitz, Elizabeth Speakman, Danuta Wojnar, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|March 27, 2020
Early Cone Photoreceptor Outer Segment Length Shortening in RPGR X-Linked Retinitis PigmentosaMoreno Menghini, Jasleen K Jolly, Anika Nanda, et al.
Palliative & Supportive Care|August 16, 2011
Clergy-laity support and patients' mood during serious illness: a cross-sectional epidemiologic studyJudith C Hays, Laura Wood, Karen Steinhauser, et al.
Cancer|November 2, 2002
A Phase II trial of pegylated liposomal doxorubicin, vincristine, and reduced-dose dexamethasone combination therapy in newly diagnosed multiple myeloma patientsMohamad A Hussein, Laura Wood, Eric Hsi, et al.
Scientific Reports|March 4, 2022
Membrane extraction with styrene-maleic acid copolymer results in insulin receptor autophosphorylation in the absence of ligandKerrie A Morrison, Laura Wood, Karen J Edler, et al.
BJU International|January 20, 2011
Phase I/II trial of subcutaneous interleukin-2, granulocyte-macrophage colony-stimulating factor and interferon-α in patients with metastatic renal cell carcinomaJorge A Garcia, Tarek Mekhail, Paul Elson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2005
Validation and extension of the Memorial Sloan-Kettering prognostic factors model for survival in patients with previously untreated metastatic renal cell carcinomaTarek M Mekhail, Rony M Abou-Jawde, Gabriel Boumerhi, et al.
Pageof 8

Showing results (21-30 of 74) with videos related to

Sort By:
Pageof 8
Clinical Genitourinary Cancer|July 25, 2006
Adjuvant subcutaneous interleukin-2 in patients with resected renal cell carcinoma: a pilot studyNavneet S Majhail, Laura Wood, Paul Elson, et al.
Investigational New Drugs|November 6, 2004
Phase II study of oral bis (aceto) ammine dichloro (cyclohexamine) platinum (IV) (JM-216, BMS-182751) given daily x 5 in hormone refractory prostate cancer (HRPC)Tahir Latif, Laura Wood, Cindy Connell, et al.
Investigational New Drugs|May 10, 2006
Phase I trial of thalidomide and interleukin-2 in patients with metastatic renal cell carcinomaThomas Olencki, Sareena Malhi, Tarek Mekhail, et al.
Nursing Outlook|September 28, 2014
Role of the registered nurse in primary health care: meeting health care needs in the 21st centuryJanice Smolowitz, Elizabeth Speakman, Danuta Wojnar, et al.
Ophthalmologica. Journal International D'Ophtalmologie. International Journal of Ophthalmology. Zeitschrift Fur Augenheilkunde|March 27, 2020
Early Cone Photoreceptor Outer Segment Length Shortening in RPGR X-Linked Retinitis PigmentosaMoreno Menghini, Jasleen K Jolly, Anika Nanda, et al.
Palliative & Supportive Care|August 16, 2011
Clergy-laity support and patients' mood during serious illness: a cross-sectional epidemiologic studyJudith C Hays, Laura Wood, Karen Steinhauser, et al.
Cancer|November 2, 2002
A Phase II trial of pegylated liposomal doxorubicin, vincristine, and reduced-dose dexamethasone combination therapy in newly diagnosed multiple myeloma patientsMohamad A Hussein, Laura Wood, Eric Hsi, et al.
Scientific Reports|March 4, 2022
Membrane extraction with styrene-maleic acid copolymer results in insulin receptor autophosphorylation in the absence of ligandKerrie A Morrison, Laura Wood, Karen J Edler, et al.
BJU International|January 20, 2011
Phase I/II trial of subcutaneous interleukin-2, granulocyte-macrophage colony-stimulating factor and interferon-α in patients with metastatic renal cell carcinomaJorge A Garcia, Tarek Mekhail, Paul Elson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2005
Validation and extension of the Memorial Sloan-Kettering prognostic factors model for survival in patients with previously untreated metastatic renal cell carcinomaTarek M Mekhail, Rony M Abou-Jawde, Gabriel Boumerhi, et al.
Pageof 8